iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
109.10
-1.06 (-0.96%)
At close: Mar 3, 2025, 4:00 PM
107.51
-1.59 (-1.46%)
Pre-market: Mar 4, 2025, 8:41 AM EST
iRhythm Technologies Employees
iRhythm Technologies had 2,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$295,920
Profits / Employee
-$56,645
Market Cap
3.43B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
IRTC News
- 11 days ago - iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - iRhythm Technologies Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect - Accesswire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out - Accesswire
- 19 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 20 days ago - iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 21 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation - Accesswire
- 22 days ago - iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire